<DOC>
	<DOCNO>NCT00823082</DOCNO>
	<brief_summary>The purpose trial study effect preoperative antithrombin supplementation patient undergoing cardiac surgery cardiopulmonary bypass order maintain antithrombin level range great 58 % functional activity , eventually , decrease negative clinical outcome ICU stay .</brief_summary>
	<brief_title>Use Antithrombin Cardiac Surgery With Cardiopulmonary Bypass</brief_title>
	<detailed_description />
	<mesh_term>Antithrombin III Deficiency</mesh_term>
	<mesh_term>Antithrombins</mesh_term>
	<mesh_term>Antithrombin III</mesh_term>
	<criteria>Male female At least 18 year age Subject need elective cardiac surgery cardiopulmonary bypass except heart transplantation Subject baseline ATIII level le 100 % equal 60 % Subject sign informed consent form Subject willing comply aspect protocol , include blood sampling , total duration study Documented congenital ATIII deficiency ATIII level 60 % Subject baseline ATIII level 100 % high Subject need emergency ( nonelective ) surgery Subject need heart transplantation History anaphylactic reaction ( ) blood blood component Allergies excipients Subject pregnant Subject medical condition accord investigator judgment worsen surgical outcome expect Subject medical condition likely interfere evaluation study treatment and/or satisfactory conduct trial accord investigator judgment Subject participate another investigational study within last 30 day previous inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>antithrombin</keyword>
	<keyword>ATIII</keyword>
	<keyword>acquire deficiency</keyword>
	<keyword>anticoagulant</keyword>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>surgery</keyword>
	<keyword>complication</keyword>
	<keyword>postoperative outcome</keyword>
</DOC>